Abstract |
Two series of new tetrahydropyrimidine (THPM)-1,2,3-triazole clubbed compounds were designed, synthesized and screened for their antitubercular (anti-TB) activity against M. tuberculosis H37Rv strain using microplate alamar blue assay (MABA). The most active compounds 5c, 5d, 5e and 5f were further examined for their cytotoxicity against the growth of RAW 264.7 mouse macrophage cells using MTT assay. The four compounds showed safety profiles better than or comparable to that of ethambutol (EMB). These compounds were evaluated for their inhibition activity against mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt). Compounds 5c and 5e were the most potent exhibiting comparable inhibition activity to that of the natural substrate deoxythymidine monophosphate ( dTMP). An in silico study was performed including docking of the most active compounds 5c and 5e into the TMPKmt (PDB: ID 1G3U) binding pocket in addition to prediction of their physicochemical and pharmacokinetic properties to explore the overall activity of these anti-TB candidates. Compounds 5c and 5e are promising anti-TB agents and TMPKmt inhibitors with acceptable oral bioavailability, physicochemical and pharmacokinetic properties.
|
Authors | Mai S El-Shoukrofy, Amal Atta, Salwa Fahmy, Dharmarajan Sriram, Mona A Mahran, Ibrahim M Labouta |
Journal | Bioorganic chemistry
(Bioorg Chem)
Vol. 131
Pg. 106312
(02 2023)
ISSN: 1090-2120 [Electronic] United States |
PMID | 36528922
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 Elsevier Inc. All rights reserved. |
Chemical References |
- dTMP kinase
- Triazoles
- Antitubercular Agents
- Nucleoside-Phosphate Kinase
|
Topics |
- Animals
- Mice
- Triazoles
(chemistry)
- Antitubercular Agents
(pharmacology, chemistry)
- Mycobacterium tuberculosis
- Nucleoside-Phosphate Kinase
- Microbial Sensitivity Tests
- Structure-Activity Relationship
- Molecular Docking Simulation
|